Table 2.
Nucleotide positions* | Adjusted p-value | Significant nt changes in OBI vs. non-OBI | Amino acid change in affected open reading frames | Affected HBV protein** | |||
---|---|---|---|---|---|---|---|
polymerase | surface | core | |||||
pre-S2 | S | ||||||
78 | 0.0144 | G → A | no change | Gly → Glu | L, M | ||
233 | 0.0367 | A → G | His → Arg (RT domain) | Thr → Ala | P, L, M, S | ||
418 | 0.0367 | G → T | Ala → Ser (RT domain) | no change | P | ||
2240 *** | 0.0097 | A → G | Thr → Val (T helper epitope) *** | C | |||
2241 *** | 0.0144 | C → T | Thr → Val (T helper epitope) *** | C | |||
2435 | 0.0367 | C → A | no change | Gln → Lys (Arg-rich C-terminus) | C | ||
2485 | 0.0367 | A → G | Asn → Ser (TP domain) | P |
* positions in the well-annotated reference HBV sequence Acc.No. AM282986
** L, M, S: Large, Middle and Small S, respectively; P: Polymerase; C: Core
*** nucleotides 2240 and 2241 co-variated in all observed cases, substituting ACT with GTT or ACA with GTA codons.